Qiagen N.V. (QGEN): $50.39
Market Cap: $10.38 B
Deal Value: $12.10 B
Sweden’s private equity firm EQT AB entered into a merger agreement on October 21, 2026, to acquire molecular testing company Qiagen in a $12.10 billion deal, ending years of takeover speculation surrounding the Dutch firm.
Qiagen shareholders will receive €46.50 ($52.29) in cash per share…